INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 419m ago
House PTR19m ago
SEC 13F18m ago
Robinhood Chain18m ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,558 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
MM
Mensinger MikeChief Product Officer
BBNXBeta Bionics, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
2,200 sh
Jan 6, 2026Jan 7, 2026
Page 1527 of 1814
← PrevNext →
traded Jan 6, 2026
+1d
SEC Form 4

Evidence

9
CT
Cabot Jeffrey TChief Accounting Officer
STEMSTEM, INC.
Grant or award
A—
3,500 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
GC
Griffith Curtis CDirector, Chairman and CEO
SPFISOUTH PLAINS FINANCIAL, INC.
Grant or award
A—
10.6K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
NO
Newhouse Steven ODirector
RDDTReddit, Inc.
Grant or award
A—
87 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
BL
Bolger LesleySee Remarks
THRYThryv Holdings, Inc.
Tax withholding
F$29K
5,047 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
BM
Buten MatthewChief Financial Officer
BHVNBiohaven Ltd.
Tax withholding
F$26K
2,594 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
AK
Ammerman Douglas KDirector
FGF&G Annuities & Life, Inc.
Grant or award
A—
762 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
TE
Taylor Timothy EvanDirector, VP, Finance & Operations
GSATGlobalstar, Inc.
Grant or award
A—
780 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
GP
Gale Mary PorterDirector
RDDTReddit, Inc.
Grant or award
A—
81 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
DN
Davarpanah Nicole NegarChief Medical Officer
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
8,333 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
NT
Newsom Cory TDirector, President
SPFISOUTH PLAINS FINANCIAL, INC.
Grant or award
A—
18.0K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
CT
Cabot Jeffrey TChief Accounting Officer
STEMSTEM, INC.
Grant or award
A—
7,000 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
VC
Voinovich Michael CDirector
GBFHGBank Financial Holdings Inc.
Grant or award
A$10K
280 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

9
GD
Glenn DylanDirector
IDNIntellicheck, Inc.
Grant or award
A—
2,355 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
NM
Navratil Chris MChief Financial Officer
EQBKEQUITY BANCSHARES INC
Grant or award
A—
23.2K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
CT
Cabot Jeffrey TChief Accounting Officer
STEMSTEM, INC.
Grant or award
A—
3,500 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
MS
McGinnis Eric SPresident, Climate Solutions
MODMODINE MANUFACTURING CO
Option exercise
M—
2,071 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
CS
Chakraborty SayanDirector
TRUTransUnion
Grant or award
A—
836 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
DM
David Bryant MitchellChief Wholesale Banking Office
FNBFNB CORP/PA/
Tax withholding
F$29K
1,690 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

9
DN
Davarpanah Nicole NegarChief Medical Officer
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
5,000 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
CK
Connors Michele KimGeneral Counsel
AMBQAmbiq Micro, Inc.
Grant or award
A—
23.8K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
DN
Davarpanah Nicole NegarChief Medical Officer
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
62.6K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
YC
Yarkoni CharlotteDirector
TRUTransUnion
Grant or award
A—
836 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
DN
Davarpanah Nicole NegarChief Medical Officer
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
30.0K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
EL
Engstrom Jamie LDirector
AEEAMEREN CORP
Grant or award
A—
1,686 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
SM
Sems Richard MChief Executive Officer, Bank
EQBKEQUITY BANCSHARES INC
Grant or award
A—
61.9K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
CC
Canale-Theakston CarinDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
1,400 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
LK
Lefferts KellyEVP, Chief Legal Officer
BLMNBloomin' Brands, Inc.
Grant or award
A—
46.3K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
KA
Knutson AnnChief Human Resources Officer
EQBKEQUITY BANCSHARES INC
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
GC
Griffith Curtis CDirector, Chairman and CEO
SPFISOUTH PLAINS FINANCIAL, INC.
Tax withholding
F$42K
1,108 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
SR
Spencer RyanDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
4,250 sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
MJ
Merson JamesDirector
CDTXCidara Therapeutics, Inc.
Disposition to issuer
D—
11.1K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence

9
BD
Black DondiDirector
IDNIntellicheck, Inc.
Grant or award
A—
785 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
AG
Auwaerter Paul GisbertDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
FG
Freeman GrantPresident
THRYThryv Holdings, Inc.
Tax withholding
F$39K
6,655 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
KM
Kelliher MikeDirector
CAPRCAPRICOR THERAPEUTICS, INC.
Grant or award
A—
15.5K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

9
SS
Siddiqui SarahEVP, CHRO
NDSNNORDSON CORP
Tax withholding
F$29K
117 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

8
PG
Patel Rahul G.Director, See remarks below
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$194K
2,282 sh
Jan 6, 2026Jan 7, 2026
traded Jan 6, 2026
+1dSEC Form 4

Evidence

7
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise · 10b5-1 plan
M—
29.3K sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC Form 4

Evidence

5
BS
Beri SanjayDirector, CEO and Chairman
NTSKNetskope Inc
Derivative conversion
C—
31.6K sh
Jan 7, 2026Jan 7, 2026
traded Jan 7, 2026
+0dSEC Form 4

Evidence